NRG BN002: Phase I study of checkpoint inhibitors anti-CTLA-4, anti-PD-1, the combination in patients with newly diagnosed glioblastoma. Other Scholarly Work

cited authors

  • Sloan, Andrew E; Gilbert, Mark R; Zhang, Peixin; Aldape, Kenneth D; Wu, Jing; Rogers, Lisa R; Wen, Patrick Y; Barani, Igor J; Iwamoto, Fabio Massaiti; Raval, Raju R; Voloschin, Alfredo Daniel; De Groot, John Frederick; Won, Minhee; Mehta, Minesh P

sustainable development goals

authors

publication date

  • May 20, 2018

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

WoS ID

  • 000442916001262

Digital Object Identifier (DOI)

volume

  • 36

issue

  • 15